Search for Clinical Trial Results

Sponsored By

Coats Disease - 2 Studies Found

Status Study
Completed Study Name: Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Condition: Coat's Disease
Date: 2005-09-13
Interventions: Drug: anecortave acetate
Completed Study Name: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Condition:
  • Coats' Disease
  • Idiopathic Retinal Telangiectasia
  • Date: 2007-05-04
    Interventions: Drug: ranibizumab injection (0.5 mg) ranibizumab 10mg mg/ml. , 0.3ml/vial, 0.05 ml./injection intravitre